Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Moore

Showing results (1-10 of 319) with videos related to

Pageof 32
Sort By:
Nature Medicine|March 8, 2012
HIV-1 Env antibodies: are we in a bind or going blind?John P Moore
Current HIV Research|April 21, 2025
The RV144 Trial Set Back HIV-1 Vaccine Development but Might Still Yield Useful InformationJohn P Moore
Nature|August 27, 2010
Misconduct: don't penalize the honest majority of scientistsJohn P Moore
Nature|February 27, 2004
HIV denialists will exploit any journal's toleranceJohn P Moore
Nature|February 25, 2005
Online submission makes authors do all the workJohn P Moore
JAMA|March 4, 2021
Approaches for Optimal Use of Different COVID-19 Vaccines: Issues of Viral Variants and Vaccine EfficacyJohn P Moore
Nature|February 3, 2017
Publishing: Journals, do your own formattingJohn P Moore
Nature|January 25, 2002
AIDS vaccines: on the trail of two trialsJohn P Moore
The New England Journal of Medicine|January 22, 2005
Topical microbicides become topicalJohn P Moore
Science (New York, N.Y.)|November 10, 2007
Speaking out about U.S. science outputJohn P Moore
Pageof 32

Showing results (1-10 of 319) with videos related to

Sort By:
Pageof 32
Nature Medicine|March 8, 2012
HIV-1 Env antibodies: are we in a bind or going blind?John P Moore
Current HIV Research|April 21, 2025
The RV144 Trial Set Back HIV-1 Vaccine Development but Might Still Yield Useful InformationJohn P Moore
Nature|August 27, 2010
Misconduct: don't penalize the honest majority of scientistsJohn P Moore
Nature|February 27, 2004
HIV denialists will exploit any journal's toleranceJohn P Moore
Nature|February 25, 2005
Online submission makes authors do all the workJohn P Moore
JAMA|March 4, 2021
Approaches for Optimal Use of Different COVID-19 Vaccines: Issues of Viral Variants and Vaccine EfficacyJohn P Moore
Nature|February 3, 2017
Publishing: Journals, do your own formattingJohn P Moore
Nature|January 25, 2002
AIDS vaccines: on the trail of two trialsJohn P Moore
The New England Journal of Medicine|January 22, 2005
Topical microbicides become topicalJohn P Moore
Science (New York, N.Y.)|November 10, 2007
Speaking out about U.S. science outputJohn P Moore
Pageof 32